Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting

Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting / Bettelli, S.; Marcheselli, R.; Pozzi, S.; Marcheselli, L.; Papotti, R.; Forti, E.; Cox, M. C. C.; Di Napoli, A.; Tadmor, T.; Mansueto, G. R.; Musto, P.; Flenghi, L.; Quintini, M.; Galimberti, S.; Lalinga, V.; Donati, V.; Maiorana, A.; Polliack, A.; Sacchi, S.. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - 104:(2021), pp. 106552-106552. [10.1016/j.leukres.2021.106552]